Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Recommendations for In Vitro and In Vivo Testing of Magnetic Nanoparticle Hyperthermia Combined with Radiation Therapy.

Spirou SV, Costa Lima SA, Bouziotis P, Vranješ-Djurić S, Efthimiadou EΚ, Laurenzana A, Barbosa AI, Garcia-Alonso I, Jones C, Jankovic D, Gobbo OL.

Nanomaterials (Basel). 2018 May 6;8(5). pii: E306. doi: 10.3390/nano8050306. Review.

2.

Complementary approaches for the evaluation of biocompatibility of 90Y-labeled superparamagnetic citric acid (Fe,Er)3O4 coated nanoparticles.

Antic B, Boskovic M, Nikodinovic-Runic J, Ming Y, Zhang H, Bozin ES, Janković D, Spasojevic V, Vranjes-Djuric S.

Mater Sci Eng C Mater Biol Appl. 2017 Jun 1;75:157-164. doi: 10.1016/j.msec.2017.02.023. Epub 2017 Feb 10.

PMID:
28415449
3.

Investigating an organ-targeting platform based on hydroxyapatite nanoparticles using a novel in situ method of radioactive ¹²⁵Iodine labeling.

Ignjatović N, Vranješ Djurić S, Mitić Z, Janković D, Uskoković D.

Mater Sci Eng C Mater Biol Appl. 2014 Oct;43:439-46. doi: 10.1016/j.msec.2014.07.046. Epub 2014 Jul 19.

PMID:
25175234
4.

Preparation and in vivo evaluation of multifunctional ⁹⁰Y-labeled magnetic nanoparticles designed for cancer therapy.

Radović M, Calatayud MP, Goya GF, Ibarra MR, Antić B, Spasojević V, Nikolić N, Janković D, Mirković M, Vranješ-Đurić S.

J Biomed Mater Res A. 2015 Jan;103(1):126-34. doi: 10.1002/jbm.a.35160. Epub 2014 Mar 20.

PMID:
24616186
5.

Comparison of chromatographic methods for quality control of DMSA complexes with 99mTc and 188Re at (III) and (V) oxidation states.

Garnuszek P, Pawlak D, Maurin M, Jankovic D, Karczmarczyk U, Mikołajczak R.

Nucl Med Rev Cent East Eur. 2012 Aug 30;15(2):95-100.

6.

90Y-labeled tin fluoride colloid as a promising therapeutic agent: preparation, characterization, and biological study in rats.

Jankovic D, Vranjes-Djuric S, Djokic D, Markovic M, Ajdinovic B, Jaukovic L, Nikolic N.

J Pharm Sci. 2012 Jun;101(6):2194-203. doi: 10.1002/jps.23114. Epub 2012 Mar 13.

PMID:
22415405
7.

[The effect of applied cytotoxic drugs on biological behaviour of 99mTc-radiopharmaceuticals].

Janković D, Dokić D, Nikolić N, Glodić P.

Med Pregl. 2010 Nov-Dec;63(11-12):758-62. Serbian.

PMID:
21553449
8.

Preparation and biodistribution of radiolabeled fullerene C60 nanocrystals.

Nikolić N, Vranjes-Ethurić S, Janković D, Ethokić D, Mirković M, Bibić N, Trajković V.

Nanotechnology. 2009 Sep 23;20(38):385102. doi: 10.1088/0957-4484/20/38/385102. Epub 2009 Aug 28.

PMID:
19713574
9.

Clinical investigations of 99mTc-p-aminohippuric acid as a new renal agent.

Jaksić E, Artiko V, Beatović S, Djokić D, Janković D, Saranović DS, Han R, Obradović V.

Nucl Med Commun. 2009 Jan;30(1):76-81.

PMID:
19306517
10.

Labeling, characterization, and in vivo localization of a new 90Y-based phosphonate chelate 2,3-dicarboxypropane-1,1-diphosphonic acid for the treatment of bone metastases: Comparison with 99mTc-DPD complex.

Djokić DDj, Janković DLj, Nikolić NS.

Bioorg Med Chem. 2008 Apr 15;16(8):4457-65. doi: 10.1016/j.bmc.2008.02.062. Epub 2008 Mar 10.

PMID:
18331797
12.

Chemical and biological evaluation of technetium (I) tricarbonyl complexes with EHIDA and DPD. 99m (I) complexes of EHIDA and DPD.

Djokić DDj, Janković DLj, Stamenković LLj, Pirmettis I.

Nucl Med Rev Cent East Eur. 2004;7(1):1-5.

PMID:
15318303

Supplemental Content

Loading ...
Support Center